COVID-19
Vaccine exemption appeal knocked back
A pharmacist’s “vaccine hesitant” views have been heard in her quest to gain an exemption from the vaccine mandate The Queensland Industrial Relations Commission heard that the pharmacist was working …
Research Roundup
Debbie Rigby takes a look at the latest in research news Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum? Multiple therapeutic options for COVID-19 are …
Provisional approval for kids’ booster
Pfizer’s Comirnaty has been provisionally approved as a booster shot for 12 to 15 year olds But the Australian Technical Advisory Group on Immunisation says it does not currently recommend …
New COVID medicine listing
Oral antiviral Paxlovid to be added to the PBS from 1 May as a treatment for COVID-19 Community pharmacists can expect to see PBS-subsidised scripts of the oral anti-viral medicine …
Anti-vax pharmacist claims profession lying about COVID jabs
A Victorian pharmacist claimed that Pharmacy Board members were complicit in treason, and questioned its authority to suspend her registration A pharmacist’s attempt to keep practising after an immediate suspension …
World News Wrapup: 7 April 2022
Man who allegedly killed pharmacist brother over COVID jabs found incompetent for trial; NZ Labour MP says discounting “like a predatory business model;” AstraZeneca sues pharmacist over alleged $8 million …
Pharmacist creates medical Wordle
Move over, Wordle, Meddle has arrived – and co-designed by a top Australian pharmacist, it has a serious side A new medical word game is now challenging health professionals, but …
Research roundup
Debbie Rigby rounds up the latest in research news Risks and burdens of incident diabetes in long COVID A large US cohort study has found a 40% increased risk of …
Psychology of pain: COVID makes life worse for chronic pain patients
Lockdown stress has hit chronic pain patients hard but those with more resilience, flexibility and acceptance have coped better, research finds. Chronic pain patients experienced increased pain, anxiety, depression and …
Molnupiravir: an oral treatment to add to the COVID-19 arsenal
The Therapeutic Goods Administration (TGA) has granted provisional approval for two new oral medications that are indicated for use in mild-to-moderate COVID-19 infections to prevent disease progression and hospitalisations. What …
Pharmacy jabs: the near future
Bivalent COVID boosters, a combined COVID and flu shot, and primary care taking on the entire vaccination framework – how could the near future look for jabs in Australia? With …
Daily Dose Day Two
The highlights of APP Day Two: Health Minister announces major changes around COVID and medicines affordability, plus the Guild and ACP join forces APP 2022 has continued into day two …